Syringe Closure System Allows Use of Highly Sensitive Compounds
Vetter’s Vetter-Ject closure system for prefilled syringes has an integrated needle hub and shield and is designed for sensitive compounds, such as biologics.
Vetter’s Vetter-Ject closure system for prefilled syringes has an integrated needle hub and shield and is designed for sensitive compounds, such as biologics. The system’s baked-in siliconization process for the glass barrel allows the silicon content to be customized. The percentage of silicon used can be reduced up to 80% compared to standard siliconization processes used in conventional syringe systems, which makes the system suitable for silicon-sensitive drug products. The closure is tamper-evident; plastic bridges are broken when the needle shield is removed. The system can be used with a wide range of primary packaging options, such as stoppers and glass barrels.
Vetter Pharma International GmbH
www.vetter-pharma.com
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
